177 related articles for article (PubMed ID: 3026016)
21. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.
Kazmierczak A; Duez JM; Pechinot A; Nordmann P; Labia R
Rev Infect Dis; 1986; 8 Suppl 5():S549-54. PubMed ID: 3026003
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field].
Nakao Y; Kimura H; Miura K; Miyajima Y; Ishikawa H; Hayakawa F; Kuno K
Jpn J Antibiot; 1989 Mar; 42(3):639-50. PubMed ID: 2746847
[TBL] [Abstract][Full Text] [Related]
23. A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
Mehtar S; Croft RJ; Hilas A
J Antimicrob Chemother; 1986 Mar; 17(3):389-96. PubMed ID: 3009384
[TBL] [Abstract][Full Text] [Related]
24. Acute neck infections in children.
Cengiz AB; Kara A; Kanra G; Seçmeer G; Ceyhan M; Ozen M
Turk J Pediatr; 2004; 46(2):153-8. PubMed ID: 15214745
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of sulbactam/ampicillin in children].
Ito S; Mayumi M; Ito M; Mikawa H
Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
27. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
Löffler L; Bauernfeind A; Keyl W; Hoffstedt B; Piergies A; Lenz W
Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
[TBL] [Abstract][Full Text] [Related]
28. Cyclacillin, a semisynthetic aminoalicyclic penicillin. I. Antibacterial activity in vitro and in vivo compared with ampicillin and cephalexin.
Yurchenco JA; Hopper MW; Vince TD; Warren GH
Chemotherapy; 1970; 15(4):209-21. PubMed ID: 4394267
[No Abstract] [Full Text] [Related]
29. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
[TBL] [Abstract][Full Text] [Related]
30. Sulbactam: biochemical factors involved in its synergy with ampicillin.
Labia R; Morand A; Lelievre V; Mattioni D; Kazmierczak A
Rev Infect Dis; 1986; 8 Suppl 5():S496-502. PubMed ID: 3025996
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial activity and kill kinetics of ampicillin/sulbactam (CP-45899) combinations against Escherichia coli and Klebsiella aerogenes.
Fuglesang JE; Bergan T
Infection; 1984; 12(1):46-50. PubMed ID: 6323321
[TBL] [Abstract][Full Text] [Related]
32. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
Traub WH; Leonhard B
Chemotherapy; 1995; 41(5):345-52. PubMed ID: 8521736
[TBL] [Abstract][Full Text] [Related]
33. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
[TBL] [Abstract][Full Text] [Related]
34. Sulbactam/ampicillin in the treatment of pediatric infections.
Kanra G; Secmeer G; Akalin E; Ecevit Z; Calikoglu AS; Gunel M; Tarim O
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):185S-187S. PubMed ID: 2591177
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
Bassetti D; Solbiati M; Ravelli A; Martini A; Viola S; Burgio RG
APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
[TBL] [Abstract][Full Text] [Related]
36. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
Kulhanjian J; Dunphy MG; Hamstra S; Levernier K; Rankin M; Petru A; Azimi P
Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
[TBL] [Abstract][Full Text] [Related]
37. Ampicillin-sulbactam monotherapy in infants with febrile urinary tract infections.
Song JY; Yoo S; Lim TJ; Byun JH; Jo KJ; Kim HY; Park SE; Kim SH
Pediatr Int; 2021 Apr; 63(4):430-435. PubMed ID: 32885532
[TBL] [Abstract][Full Text] [Related]
38. [Ampicillin and combination penicillins in clinical medicine (antibacterial effects)].
Metz H
Munch Med Wochenschr; 1972 Sep; 114(35):1515-9. PubMed ID: 4628080
[No Abstract] [Full Text] [Related]
39. [Clinical studies on sulbactam/ampicillin in the field of pediatrics].
Iwata S; Yamada K; Sato Y; Ishikawa K; Akita H; Sunakawa K
Jpn J Antibiot; 1989 Mar; 42(3):598-611. PubMed ID: 2664249
[TBL] [Abstract][Full Text] [Related]
40. Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Shungu DL; Ponticas S; Gill CJ
Clin Ther; 1989; 11(3):315-8. PubMed ID: 2663161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
